Endymed Ltd
Endymed Ltd
Share · IL0011010217 (XTAE)
Overview
No Price
n/a
Company Profile for Endymed Ltd Share
Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Its products comprise EndyMed PRO, a multi-application treatment platform; PURE 2.0 that offers professional skin tightening, body contouring, and functional resurfacing; and 3DEEP radiofrequency technology, a solution for the treatment of skin tightening, wrinkle reduction, body contouring, texture enhancement, cellulite reduction, circumferential reduction, acne and acne scar reduction, stretch mark reduction, RF micro needling, and fractional resurfacing. The company was founded in 2007 and is based in Freehold, New Jersey.
Get up to date insights from finAgent about Endymed Ltd

Company Data

Name Endymed Ltd
Company Endymed Ltd
Website https://www.endymed.com
Primary Exchange XTAE TASE
ISIN IL0011010217
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Yossi Bar-On CPA
Market Capitalization 44 Mio
Country United States of America
Currency ILA
Employees 0,0 T
Address 4400 Route 9 South, 07728 Freehold
IPO Date 2007-07-19

Ticker Symbols

Name Symbol
TASE ENDY.TA
More Shares
Investors who hold Endymed Ltd also have the following shares in their portfolio:
ABU DH.N.E. 19/49 MTN
ABU DH.N.E. 19/49 MTN Bond
VIRGIN MED.FI. 20/30 REGS
VIRGIN MED.FI. 20/30 REGS Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025